Perinatal, Metabolic and Reproductive Features in PPARG -related Lipodystrophy

Archive ouverte

Gosseaume, Camille | Fournier, Thierry | Jéru, Isabelle | Vignaud, Marie-Léone | Missotte, Isabelle | Archambeaud, Françoise | Debussche, Xavier | Droumaguet, Céline | Fève, Bruno | Grillot, Sophie | Guerci, Bruno | Hieronimus, Sylvie | Horsmans, Yves | Nobécourt, Estelle | Pienkowski, Catherine | Poitou, Christine | Thissen, Jean-Paul | Lascols, Olivier | Degrelle, Séverine | Tsatsaris, Vassilis | Vigouroux, Corinne | Vatier, Camille

Edité par CCSD ; Oxford Univ. Press -

International audience. Abstract Objective The adipogenic PPARG-encoded PPARγ nuclear receptor also display essential placental functions. We evaluated metabolic, reproductive and perinatal features of patients with PPARG-related lipodystrophy. Methods Current and retrospective data were collected in patients referred to a National Rare Diseases Reference Centre. Results 26 patients from 15 unrelated families were studied (18 women, median age 43 years). They carried monoallelic PPARG variants except a homozygous patient with congenital generalized lipodystrophy. Among heterozygous patients aged 16 or more (n = 24), 92% had diabetes, 96% partial lipodystrophy (median age at diagnosis 24 and 37 years, respectively), 78% hypertriglyceridemia, 71% liver steatosis and 58% hypertension. Mean BMI was 26 ± 5.0 kg/m2. Women (n = 16) were frequently affected by acute pancreatitis (n = 6) and/or polycystic ovary syndrome (n = 12). Eleven women obtained one or several pregnancies, all complicated by diabetes (n = 8), hypertension (n = 4) and/or hypertriglyceridemia (n = 10). We analysed perinatal data of patients according to the presence (n = 8) or absence (n = 9) of maternal dysmetabolic environment. The median gestational age at birth was low in both groups (37 and 36 weeks of amenorrhea, respectively). As expected, birth weight was higher in patients exposed to a fetal dysmetabolic environment of maternal origin. In contrast, 85.7% of non-exposed patients, in whom the variant is, or is very likely to be, paternally-inherited, were small for gestational age. Conclusions Lipodystrophy-related PPARG variants induce early metabolic complications. Our results suggest that placental expression of PPARG pathogenic variants carried by affected fetuses could impair prenatal growth and parturition. This justifies careful pregnancy monitoring in affected families.

Suggestions

Du même auteur

Peroxisome proliferator‐activated receptor gamma‐ligand‐binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration

Archive ouverte | Shoaito, Hussein | CCSD

International audience. The transcription factor peroxisome proliferator-activated receptor gamma (PPARG) is essential for placental development, and alterations in its expression and/or activity are associated with...

Peroxisome proliferator‐activated receptor gamma‐ligand‐binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration

Archive ouverte | Shoaito, Hussein | CCSD

International audience. The transcription factor peroxisome proliferator-activated receptor gamma (PPARG) is essential for placental development, and alterations in its expression and/or activity are associated with...

A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies

Archive ouverte | Treiber, Guillaume | CCSD

International audience. Aims: LMNA-linked familial partial lipodystrophy type 2 (FPLD2) leads to insulin resistance-associated metabolic complications and cardiovascular diseases. We aimed to characterise the diseas...

Chargement des enrichissements...